GDC-0134
- Generic Name
- GDC-0134
- Drug Type
- Small Molecule
- Chemical Formula
- C19H20F4N6O2
- CAS Number
- 1637394-01-4
- Unique Ingredient Identifier
- 4N6KQ7D685
A Study to Determine the Bioavailability of Various Formulations of GDC-0134 in Healthy Female Participants of Non-Childbearing Potential
Phase 1
Completed
- Conditions
- Healthy Volunteers
- Interventions
- First Posted Date
- 2019-01-17
- Last Posted Date
- 2020-08-31
- Lead Sponsor
- Genentech, Inc.
- Target Recruit Count
- 38
- Registration Number
- NCT03807739
- Locations
- 🇺🇸
Covance Research Unit - Dallas, Dallas, Texas, United States
🇺🇸Covance Research Unit - Daytona, Daytona Beach, Florida, United States
Bioavailability of GDC-0134 and the Effect of Food and Proton Pump Inhibitor on Pharmacokinetics of GDC-0134 in Healthy Female Participants
Phase 1
Completed
- Conditions
- Amyotrophic Lateral Sclerosis
- Interventions
- First Posted Date
- 2017-08-02
- Last Posted Date
- 2024-03-01
- Lead Sponsor
- Genentech, Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT03237741
- Locations
- 🇬🇧
Quotient Clinical Ltd, Clinical Research Unit, Nottingham, United Kingdom
A Study of GDC-0134 to Determine Initial Safety, Tolerability, and Pharmacokinetic Parameters in Participants With Amyotrophic Lateral Sclerosis
Phase 1
Completed
- Conditions
- Amyotrophic Lateral Sclerosis
- Interventions
- First Posted Date
- 2016-01-14
- Last Posted Date
- 2020-08-06
- Lead Sponsor
- Genentech, Inc.
- Target Recruit Count
- 54
- Registration Number
- NCT02655614
- Locations
- 🇺🇸
Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
🇺🇸Mayo Clinic Hospital - Florida, Jacksonville, Florida, United States
🇺🇸Forbes Norris Mda/als Ctr; Research Center, San Francisco, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath